Properties and clinical use of perfluorocarbons
Kościelak, J.; Scharf, R.
Acta Haematologica Polonica 17(1-2): 56-62
1986
ISSN/ISBN: 0001-5814 PMID: 3535344 Document Number: 274280
Document emailed within 1 workday
Related Documents
Strmen, P. 1995: Use of liquid perfluorocarbons in ophthalmology Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 51(5): 310-316Rüdiger, S.; Gross, U.; Kemnitz, E. 2000: Perfluorocarbons useful tools for medicine European Journal of Medical Research 5(5): 209-216
Max, M.; Roissant, R. 2000: Intravenous perfluorocarbons: 30 years of research--what now? Deutsche Medizinische Wochenschrift 125(15): 444
Tooley, R.; Hirschl, R.B.; Parent, A.; Bartlett, R.H. 1996: Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis Critical Care Medicine 24(2): 268-273
Olesen, H.; Cowan, D.; Bruunshuus, I.; Klempel, K.; Hill, G. 1997: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. Properties and units in the clinical laboratory sciences. VI. Properties and units in IOC prohibited drugs (IUPAC-IFCC recommendations 1997) European Journal of Clinical Chemistry and Clinical Biochemistry 35(10): 805-831
Ermolenko, V.M.; Nikolaev, A.I. 1990: Erythropoietin: its biological properties and clinical use Terapevticheskii Arkhiv 62(11): 141-145
Abdelmoula, J.; Kaabachi, N.; Mebazaa, A. 1990: Fibronectin: biologic properties and clinical significance La Tunisie Medicale 68(4): 245-249
Sobkowiak, E.M.; Held, M. 1979: The use of composites (with referenceto their technological and clinical properties) Stomatologie der DDR 29(3): 221-229
Mamaladze, M.T.; Sanodze, L.O. 2008: Clinical properties of mineral trioxide aggregate Georgian Medical News 164: 33-38
Mashkovskiĭ, M.D.; Iuzhakov, S.D.; Absava, G.I.; Erokhina, L.G.; Lebedeva, N.V. 1984: Pharmacological properties and clinical use of xanthinol nicotinate Klinicheskaia Meditsina 62(11): 30-34
Lebel-Binay, S.; Berger, A.; Zinzindohoué, F.; Cugnenc, P.; Thiounn, N.; Fridman, W.H.; Pagès, F. 2000: Interleukin-18: biological properties and clinical implications European Cytokine Network 11(1): 15-26
Reymond, C.; Rivier, J.L. 1973: Clinical study of the antiarrhythmic properties of amiodarone Therapeutische Umschau. Revue Therapeutique 30(3): 223-230
Vorpahl, W.D. 1981: The roentgen-optical and clinical properties of peritrast Die Medizinische Welt 32(47): 1790-1793
Penner, J.A.; Hunter, M.J. 1976: Antithrombins: clinical aspects, chemical and biologic properties Progress in Clinical and Biological Research 5: 277-300
Bel'kov, A.V.; Pisarevskiĭ, A.A. 1991: Live isolated liver cells, their properties and clinical use Anesteziologiia i Reanimatologiia 3: 75-77
Babuty, D.; Neville, P.; Aupart, M.; Rouchet, S.; Marchand, M.; Fauchier, J.P.; Cosnay, P. 1993: Electrophysiological properties of the transplanted heart. Clinical applications Archives des Maladies du Coeur et des Vaisseaux 86(7): 1053-1060
Kochsiek, K. 1982: Clinical consequences of pharmacokinetic properties of cardiac glycosides European Heart Journal 3 Suppl D: 79-86
Kurtz, E.S.; Wallo, W. 2007: Colloidal oatmeal: history, chemistry and clinical properties Journal of Drugs in Dermatology: Jdd 6(2): 167-170
Young, E.R.; Mason, D.R.; Saso, M.A.; Albert, B.S. 1989: Some clinical properties of Octocaine 200 (2 per cent lidocaine with epinephrine 1:200,000) Journal 55(12): 987-991
Iselin, W.; Oddera, M.; Lufi, A. 1986: The flexible gingival mask. Indications and clinical properties. i Dental Cadmos 54(20): 57-65